Sun Pharmaceutical Industries Ltd.

The Revenue for the quarter ended  March 2022 of Rs. 40068.80 millions grew by 9.26 % from Rs. 36672.60 millions.The Net Loss for the quarter ended March 2022 is Rs. -12862.10 millions as compared to Net Profit of Rs. 1848.80 millions of corresponding quarter ended March 2021Operating profit surged to 13002.50 millions from the corresponding previous quarter of 7455.00 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202203	202103	% Var	202203	202103	% Var	202203	202103	% Var
Sales	40068.80	36672.60	9.26	155859.80	141160.50	10.41	155859.80	141160.50	10.41
Other Income	4404.90	382.70	1051.01	11968.80	1920.70	523.15	11968.80	1920.70	523.15
PBIDT	13002.50	7455.00	74.41	38654.40	24490.80	57.83	38654.40	24490.80	57.83
Interest	911.90	1053.10	-13.41	3881.00	2675.20	45.07	3881.00	2675.20	45.07
PBDT	-4459.00	5506.30	-180.98	16568.10	20920.00	-20.80	16568.10	20920.00	-20.80
Depreciation	3541.40	3220.70	9.96	13499.50	12364.30	9.18	13499.50	12364.30	9.18
PBT	-8000.40	2285.60	-450.04	3068.60	8555.70	-64.13	3068.60	8555.70	-64.13
TAX	4861.70	436.80	1013.03	4068.50	131.70	2989.22	4068.50	131.70	2989.22
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	-12862.10	1848.80	-795.70	-999.90	8424.00	-111.87	-999.90	8424.00	-111.87
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	32.45	20.33	59.63	24.80	17.35	42.95	24.80	17.35	42.95